2/6
03:11 pm
azn
AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
2/4
01:40 pm
azn
Shell chief exec to become one of FTSE's best paid bosses [Yahoo! Finance]
Low
Report
Shell chief exec to become one of FTSE's best paid bosses [Yahoo! Finance]
2/4
12:40 pm
azn
Why pharma manufacturers are still investing in Europe [Yahoo! Finance]
Low
Report
Why pharma manufacturers are still investing in Europe [Yahoo! Finance]
2/4
08:13 am
azn
IonQ to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
Low
Report
IonQ to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 [Yahoo! Finance]
2/4
06:33 am
azn
AstraZeneca Oncology Advances Gain Momentum With New Cancer Approvals In Focus [Yahoo! Finance]
Low
Report
AstraZeneca Oncology Advances Gain Momentum With New Cancer Approvals In Focus [Yahoo! Finance]
2/3
07:55 pm
azn
Why Astrazeneca (AZN) Dipped More Than Broader Market Today [Yahoo! Finance]
Low
Report
Why Astrazeneca (AZN) Dipped More Than Broader Market Today [Yahoo! Finance]
2/3
07:22 pm
azn
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results [Yahoo! Finance]
Low
Report
Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results [Yahoo! Finance]
2/3
12:02 pm
azn
Jim Cramer Says “I Like AstraZeneca Very Much” [Yahoo! Finance]
Low
Report
Jim Cramer Says “I Like AstraZeneca Very Much” [Yahoo! Finance]
2/3
10:56 am
azn
Walmart hits US$1 trillion in market value for the first time [BNN Bloomberg (Canada)]
Low
Report
Walmart hits US$1 trillion in market value for the first time [BNN Bloomberg (Canada)]
2/3
07:23 am
azn
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy [Yahoo! Finance]
Low
Report
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy [Yahoo! Finance]
2/3
07:00 am
azn
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
Low
Report
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
2/3
04:47 am
azn
AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals [Yahoo! Finance]
Low
Report
AstraZeneca PLC (NASDAQ:AZN) Announces Strategic Collaboration Agreement With CSPC Pharmaceuticals [Yahoo! Finance]
2/3
02:53 am
azn
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy [Yahoo! Finance]
Low
Report
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy [Yahoo! Finance]
2/2
02:15 pm
azn
US and India reach trade deal, Astrazeneca shares move to NYSE [Yahoo! Finance]
Low
Report
US and India reach trade deal, Astrazeneca shares move to NYSE [Yahoo! Finance]
2/2
09:15 am
azn
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer [Yahoo! Finance]
Low
Report
NYSE Content Advisory: Pre-Market update + AstraZeneca Shares Begin Trading on NYSE in Record Transfer [Yahoo! Finance]
2/2
07:18 am
azn
AstraZeneca begins trading on the New York Stock Exchange [Yahoo! Finance]
Low
Report
AstraZeneca begins trading on the New York Stock Exchange [Yahoo! Finance]
2/2
07:00 am
azn
AstraZeneca begins trading on the New York Stock Exchange
Low
Report
AstraZeneca begins trading on the New York Stock Exchange
2/2
04:51 am
azn
AstraZeneca Shares to Start Trading in US After Listing Upgrade [Yahoo! Finance]
Low
Report
AstraZeneca Shares to Start Trading in US After Listing Upgrade [Yahoo! Finance]
2/2
04:51 am
azn
AstraZeneca Shares to Start Trading in US After Listing Upgrade [Yahoo! Finance Canada]
Low
Report
AstraZeneca Shares to Start Trading in US After Listing Upgrade [Yahoo! Finance Canada]
2/2
04:18 am
azn
AstraZeneca to Begin NYSE Trading; Says Imfinzi Recommended by EU as Gastric Cancer Treatment [Yahoo! Finance]
Low
Report
AstraZeneca to Begin NYSE Trading; Says Imfinzi Recommended by EU as Gastric Cancer Treatment [Yahoo! Finance]
2/1
10:36 pm
azn
BeOne Medicines Deepens InSysBio Partnership To Refine Oncology Trial Risk [Yahoo! Finance]
Low
Report
BeOne Medicines Deepens InSysBio Partnership To Refine Oncology Trial Risk [Yahoo! Finance]
2/1
07:52 pm
azn
CNBC Daily Open: Markets see Warsh as a safe pick for Fed chair — causing gold and silver to plunge [CNBC]
Low
Report
CNBC Daily Open: Markets see Warsh as a safe pick for Fed chair — causing gold and silver to plunge [CNBC]
2/1
07:03 pm
azn
CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies [Yahoo! Finance]
Low
Report
CSPC AstraZeneca Deal Recasts Role In Global Obesity And Diabetes Therapies [Yahoo! Finance]
2/1
04:13 am
azn
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation [MSNBC.com]
Low
Report
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation [MSNBC.com]
2/1
02:50 am
azn
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation [CNBC]
Low
Report
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation [CNBC]